The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
April 29th 2025
A 15-mg dose with a corticosteroid taper regimen was superior to placebo in sustained remission from week 12 to 52.
Acquisition of Health Plan Provider to Create New Enterprise for Insurance Company
March 28th 2019The acquisition of Wellcare Health Plans will create a centralized health care enterprise focused on government-sponsored health care programs on the forefront of Medicaid, Medicare, and the Health Insurance Marketplace for Centene.
Read More
Generic Drug for Stroke Prevention Granted FDA Approval
March 27th 2019Lannett officials said that the company received approval of its Abbreviated New Drug Application (ANDA) for Aspirin and Extended-Release Dipyridamole Capsules, 25 mg/200 mg, a generic version of Aggrenox® Capsules, 25 mg/200 mg (Boehringer Ingelheim Pharmaceuticals).
Read More
Opioid Maker Agrees to Pay $270M for Addiction Treatment in Oklahoma
March 27th 2019Oklahoma Attorney General Mike Hunter filed a lawsuit against Purdue Pharma and 3 other manufacturers of opioid pain medications in 2017. In the filing on behalf of the state, he claimed these companies utilized deceptive marketing campaigns over the previous decade, which helped fuel the state’s opioid epidemic.
Read More
Guide Offers 15 Actions to Foster Adoption of Pharmacist-Provided Care
March 27th 2019According to PQA, pharmacist-provided care can transform the pharmacist’s role in health care from a medication dispenser to an indispensable clinical care team member providing affordable, accessible and high-quality health care services that improve patient outcomes.
Read More
Comparable Efficacy of Generic and Brand-Name Drugs for Chronic Conditions Shown in Study
March 26th 2019Although generic versions of prescription medications can be a cheaper alternative for patients, many perceive generics as less effective and less safe than their brand-name counterparts.
Read More